Kolexia
Jouve Eva
Gynécologie
Institut Universitaire du Cancer Toulouse Oncopole
Toulouse, France
79 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Carcinomes Tumeurs de l'ovaire Métastase lymphatique Micrométastase tumorale Métastase tumorale Carcinome canalaire du sein Adénocarcinome Tumeurs du péritoine

Industries

MSD
6 collaboration(s)
Dernière en 2023
Daiichi Sankyo
4 collaboration(s)
Dernière en 2022
Pfizer
3 collaboration(s)
Dernière en 2023
Lilly
2 collaboration(s)
Dernière en 2023

Dernières activités

Oncologic safety of autologous fat grafting in primary breast reconstruction after mastectomy for cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology   15 février 2024
Axillary Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node: A Non Inferiority Randomized Multicenter Phase III Trial of Axillary Node Dissection Versus no Axillary Node Dissection in Case of Positive Sentinel Lymph Node in Invasive Breast Cancer
Essai Clinique (Centre Paoli-Calmettes)   09 janvier 2024
Triple-negative and Her2-positive breast cancer in women aged 70 and over: prognostic impact of age according to treatment.
Frontiers in oncology   15 décembre 2023
Negative Survival Impact of Occult Lymph Node Involvement in Small HER2-Positive Early Breast Cancer Treated by Up-Front Surgery.
Cancers   14 septembre 2023
MEAVANTI: Study of the Quality of Life in Patients With Standard External Breast Prosthesis Compared to Patients With Custom-made Breast Prosthesis. MEAVANTI Project.
Essai Clinique (CHU Toulouse)   06 septembre 2023
MAPAM-01: Therapeutic Nipple Areola Skin-sparing Mastectomy.
Essai Clinique (Institut Universitaire du Cancer Toulouse Oncopole)   02 août 2023
CURSOC: Cost Utility of Radical Surgery in Ovarian Cancer
Essai Clinique (Institut Universitaire du Cancer Toulouse Oncopole)   02 août 2023
Erratum to 'Systemic treatment with or without ablative therapies in oligometastatic breast cancer: A single institution analysis of patient outcomes' The Breast (2023) 102-109.
Breast (Edinburgh, Scotland)   10 mai 2023
Clinical and pathological characterization of 158 consecutive and unselected oligometastatic breast cancers in a single institution.
Breast cancer research and treatment   15 février 2023
Early breast cancer in women aged 35 years or younger: A large national multicenter French population-based case control-matched analysis.
Breast (Edinburgh, Scotland)   08 février 2023